PL357246A1 - Związek typu RGD (ARG-GLY-ASP) sprzężony z (neuro)peptydami - Google Patents

Związek typu RGD (ARG-GLY-ASP) sprzężony z (neuro)peptydami

Info

Publication number
PL357246A1
PL357246A1 PL01357246A PL35724601A PL357246A1 PL 357246 A1 PL357246 A1 PL 357246A1 PL 01357246 A PL01357246 A PL 01357246A PL 35724601 A PL35724601 A PL 35724601A PL 357246 A1 PL357246 A1 PL 357246A1
Authority
PL
Poland
Prior art keywords
gly
asp
coupled
arg
rgd
Prior art date
Application number
PL01357246A
Other languages
English (en)
Other versions
PL202279B1 (pl
Inventor
Jong Marion De
Eric Paul Krenning
Hagen Petrus Martinus Van
Original Assignee
Mallinckrodt, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt, Inc. filed Critical Mallinckrodt, Inc.
Publication of PL357246A1 publication Critical patent/PL357246A1/pl
Publication of PL202279B1 publication Critical patent/PL202279B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/082—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL357246A 2000-04-26 2001-04-26 Związek typu RGD (ARG-GLY-ASP) sprzężony z (neuro)peptydami PL202279B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201499 2000-04-26
PCT/EP2001/004764 WO2001081426A2 (en) 2000-04-26 2001-04-26 Rgd (arg-gly-asp) coupled to (neuro)peptides

Publications (2)

Publication Number Publication Date
PL357246A1 true PL357246A1 (pl) 2004-07-26
PL202279B1 PL202279B1 (pl) 2009-06-30

Family

ID=8171409

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357246A PL202279B1 (pl) 2000-04-26 2001-04-26 Związek typu RGD (ARG-GLY-ASP) sprzężony z (neuro)peptydami

Country Status (15)

Country Link
US (1) US7202330B2 (pl)
EP (2) EP1452543A3 (pl)
JP (1) JP2004517034A (pl)
AT (1) ATE272074T1 (pl)
AU (2) AU6898201A (pl)
CA (1) CA2407514C (pl)
CZ (1) CZ20023539A3 (pl)
DE (1) DE60104552T2 (pl)
ES (1) ES2225570T3 (pl)
HU (1) HUP0301571A2 (pl)
IL (1) IL152466A0 (pl)
NO (1) NO20025064L (pl)
NZ (1) NZ522200A (pl)
PL (1) PL202279B1 (pl)
WO (1) WO2001081426A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081426A2 (en) 2000-04-26 2001-11-01 Biosynthema Inc. Rgd (arg-gly-asp) coupled to (neuro)peptides
US7122622B2 (en) 2002-04-16 2006-10-17 Biosynthema Inc. Peptide compounds having improved binding affinity to somatostatin receptors
EP1358890A1 (en) 2002-05-03 2003-11-05 BioSynthema, Inc Benzothienyl analogue of somatostatine, selective for certain somatostatin receptors
US7384636B2 (en) 2003-03-31 2008-06-10 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptide
US20070025910A1 (en) 2005-07-29 2007-02-01 Norenberg Jeffrey P Anticancer therapy
CN101495437A (zh) 2006-07-24 2009-07-29 宝洁公司 用于差向异构环己烯基酮的方法以及其在羟醛缩合工艺中的应用
KR100987592B1 (ko) * 2008-03-10 2010-10-12 경북대학교 산학협력단 암진단용 ｍｒ 조영제와 그 제조방법
US9517201B2 (en) * 2008-04-04 2016-12-13 Rutgers, The State University Of New Jersey Nanocarrier and nanogel compositions
US8263133B2 (en) * 2009-02-18 2012-09-11 The Regents Of The University Of California Multivalent clustering targeting strategy for drug carriers
CN102260352B (zh) * 2010-05-28 2013-11-20 山东先声麦得津生物制药有限公司 靶向性白细胞介素融合蛋白及其制备方法与应用
US9775803B2 (en) 2011-10-19 2017-10-03 Samsung Electronics Co., Ltd. Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof
EP2922578B1 (en) * 2012-11-21 2018-12-12 Serene, Llc Tin-117m comprising somatostatin receptor binding compounds
SI3568205T1 (sl) 2017-01-12 2023-12-29 Radiomedix Inc. Zdravljenje rakastih celic, ki prekomerno izražajo receptorje za somatostatin, z uporabo derivatov okreotida, kelatiranih v radioizotope
CN107412794B (zh) * 2017-04-17 2019-01-04 中国医学科学院北京协和医院 双靶点显像分子探针及其制备方法和应用
CN106967149A (zh) * 2017-05-04 2017-07-21 苏州强耀生物科技有限公司 一种棕榈酰化修饰的半胱氨酸多肽的制备方法
PL238941B1 (pl) * 2018-04-04 2021-10-25 Gdanski Univ Medyczny Związki chemiczne o działaniu przeciwuszkodzeniowym i/lub neuroprotekcyjnym
CN116510033B (zh) * 2023-03-09 2024-03-19 哈尔滨吉象隆生物技术有限公司 一种抗肿瘤的ppc药物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2878341B2 (ja) 1989-03-03 1999-04-05 学校法人藤田学園 人工機能性ポリペプチド
US5843903A (en) * 1995-11-27 1998-12-01 The Administrators Of The Tulane Educational Fund Targeted cytotoxic anthracycline analogs
WO2001081426A2 (en) 2000-04-26 2001-11-01 Biosynthema Inc. Rgd (arg-gly-asp) coupled to (neuro)peptides

Also Published As

Publication number Publication date
ATE272074T1 (de) 2004-08-15
CZ20023539A3 (cs) 2003-09-17
EP1452543A3 (en) 2005-08-03
CA2407514C (en) 2011-03-29
HUP0301571A2 (hu) 2003-09-29
DE60104552T2 (de) 2005-09-01
US7202330B2 (en) 2007-04-10
IL152466A0 (en) 2003-05-29
EP1301540A2 (en) 2003-04-16
AU2001268982B8 (en) 2006-08-03
JP2004517034A (ja) 2004-06-10
AU6898201A (en) 2001-11-07
AU2001268982B2 (en) 2006-06-15
ES2225570T3 (es) 2005-03-16
US20040136907A1 (en) 2004-07-15
EP1452543A2 (en) 2004-09-01
WO2001081426A2 (en) 2001-11-01
WO2001081426A3 (en) 2002-06-27
NO20025064L (no) 2002-12-20
DE60104552D1 (de) 2004-09-02
NZ522200A (en) 2004-07-30
NO20025064D0 (no) 2002-10-22
PL202279B1 (pl) 2009-06-30
CA2407514A1 (en) 2001-11-01
EP1301540B1 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
AU6898201A (en) Rgd (arg-gly-asp) coupled to (neuro)peptides
PT1105409E (pt) Proteccao de peptidos terapeuticos endogenos da actividade de peptidases por conjugacao a componentes do sangue
DK1144454T4 (da) Modificerede peptider som terapeutiske midler
WO2001083525A3 (en) Modified peptides, comprising an fc domain, as therapeutic agents
IL131381A0 (en) Therapeutic agent for lymphatic tumors
DE69435105D1 (de) Derivate therapeutischer Peptide
WO2003028527A8 (en) Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
EP2298331A3 (en) Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
AU3739500A (en) Protease resistant flint analogs
EP1023906A4 (en) POTENTIATOR FOR ANTI-TUMOR ANTIBODY LYMPHOID
WO2001090139A3 (en) A ligand for enhancing oral and cns delivery of biological agents
IL150045A0 (en) Compositions and methods for detecting stress-inducible proteins
WO2002099379A3 (en) Breast homing peptides and methods of identifying same using aminopeptidase p
CA2315241A1 (en) Protein rim2
JP2002335964A5 (pl)
TW200602353A (en) Modified secretin and method of synthesizing thereof
WO2003095604A3 (en) Purified peptide deformylase from streptococcus pneumoniae

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20100426